The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
NIVORAD: A randomised phase 2 trial of nivolumab and stereotactic ablative body radiotherapy in advanced non-small cell lung cancer, progressing after first or second line chemotherapy.
 
Paul Mitchell
Honoraria - Roche
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Celgene; MSD; Roche
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Roche
 
Shankar Siva
Consulting or Advisory Role - Astellas Oncology (Inst)
Research Funding - Bristol-Myers Squibb (Inst); Merck Sharp & Dohme (Inst); Varian Medical Systems (Inst)
 
Peey Sei Kok
No Relationships to Disclose
 
Ken O'Byrne
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; MSD Oncology; Novartis; Pfizer; Roche/Genentech
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; MSD Oncology; Novartis; Pfizer; Roche/Genentech
Speakers' Bureau - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; MSD Oncology; Novartis; Pfizer; Roche/Genentech
Patents, Royalties, Other Intellectual Property - Q Queensland University of technology
Travel, Accommodations, Expenses - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; MSD Oncology; Novartis; Pfizer; Roche/Genentech
 
Annie Yeung
No Relationships to Disclose
 
Ann Livingstone
No Relationships to Disclose
 
Mark Donoghoe
No Relationships to Disclose
 
Sonia Yip
No Relationships to Disclose
 
Martin R. Stockler
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bionomics (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Medivation (Inst); Pfizer (Inst); Sanofi (Inst)